Skip to main content
. 2021 May 25;15:100270. doi: 10.1016/j.bbih.2021.100270

Table 1.

Demographic, clinical, imaging, interventional, and sampling related characteristics (n ​= ​61).

Demographics n ​= ​61
Age [years], median (IQR) 77 (68–83)
Male sex, n (%) 23 (38%)
Medical history
 Hypertension, n (%) 54 (89%)
 Diabetes mellitus, n (%) 12 (20%)
 Hyperlipidemia, n (%) 19 (31%)
 Atrial fibrillation, n (%) 35 (57%)
 Current smoker, n (%) 5 (8%)
Baseline medication
 Antithrombotic medication, n (%) 30 (49%)
 Antihypertensive drugs, n (%) 50 (82%)
Clinical characteristics
 Systolic blood pressure [mmHg], median (IQR) 160 (150–180)
 Diastolic blood pressure [mmHg], median (IQR) 85 (71–96)
 Heart rate [min-1], median (IQR) 80 (69–90)
 NIHSS at presentation, median (IQR) 15 (10–17)
 Unknown time of symptom onset, n (%) 14 (23%)
 Qualifying ASPECTS, median (IQR) 8 (7–9)
Treatment
Thrombolysis
 IV rt-PA, n (%) 25 (41%)
Intervention
 Onset-to-puncture [min], median (IQR) 255 (170–343)
 Angiographic occlusion location∗
 M1, n (%) 44 (72%)
 M2, n (%) 14 (23%)
 ICA, n (%) 10 (16%)
Stent-retrieval maneuvers, median (IQR) 2 (1–3)
 Successful recanalization, n (%) 54 (89%)
 Onset-to-recanalization time [min], median (IQR) 322 (245–389)
Sampling
Onset-to-ischemic sampling time [min], median (IQR) 282 (200–367)
Onset-to-systemic sampling time [min], median (IQR)
325 (261–401)
Ischemic-to-systemic sampling time [min], median (IQR) 33 (18–69)

ASPECTS, Alberta Stroke Program Early CT score; IV rt-PA, intravenous recombinant tissue plasminogen activator; NIHSS, National Institutes of Health Stroke Scale; ∗Including multiple sites per patient; M1/M2, middle cerebral artery section; ICA, internal carotid artery; definied as mTICI (modified treatment in cerebral infarction) scale 2b or 3.